REBOOT #230 Kittleson Rules Heart Failure

Blood-based Biomarkers, Anti-Amyloid Therapies and BeyondFrom blood-based biomarkers to anti-amyloid treatments, join us as we explore the latest in Alzheimer’s disease diagnosis and treatment with Dr. Halima Amjad. This episode will equip you to guide your patients about the lat ...  Show more

Diverticulitis Simplified: Imaging, Antibiotics, Diet, and When to Call Surgery Master diverticulitis! Learn how to distinguish uncomplicated from complicated disease, when to reach for antibiotics, and which patients need surgical consultation. We’re joined by Dr. Bob Hollis (Un ...  Show more

Herzinsuffizienz: Leitliniengerecht und zeitgemäß behandeln 

In this episode, we talk all things critical care the one and only, Dr. Jean-Louis Vincent aka. JLV. This episode is a MUST listen. We touch upon the evolution of early goal directed therapy, measures of fluid responsiveness, optimizing oxygen delivery, and the importance of inte ...  Show more

With progressing CKD & HFrEF, what GDMT medications can you start, continue or stop? What does the data on hydralazine/isosorbide tell us and what does it NOT tell us? What are the pros and cons of starting GDMT inpatient versus outpatient? Do you still keep patients on GDMT once ...  Show more

In patients with heart failure with low ejection fraction and chronic coronary disease without unstable symptoms, does stenting open blocked coronary arteries extend life or reduce hospitalizations? There is some literature to suggest those with low EF may benefit from revascular ...  Show more